JAC Advance Access originally published online on July 15, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 52, 258-263
© 2003 The British Society for Antimicrobial Chemotherapy
Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteers
1 Antibiotic Research Unit, Department of Medical Sciences, Clinical Bacteriology, Box 552, Uppsala University, S-751 22 Uppsala; 2 Swedish Institute for Infectious Disease Control, Solna, Sweden
Received 7 February 2003; returned 6 April 2003; revised 9 May 2003; accepted 18 May 2003
Background: Antibiotic resistance typically confers a biological fitness cost on bacteria that can be manifested as a decreased growth rate in culture media and experimental animals. However, there are limited experimental data on the relative fitness of resistant and susceptible bacteria during growth in their natural environment.
Objective: We have developed a human competition model to investigate the relative fitness of antibiotic-resistant and -susceptible bacteria.
Materials and methods: A non-epidemic Staphylococcus epidermidis strain was isolated from skin, and a rifampicin-resistant (RifR) clone was selected. The RifR marker was used to distinguish the inoculated strains from the resident population of coagulase-negative staphylococci. The RifR strains were further selected for resistance to ciprofloxacin (CipR) and fusidic acid (FusR). A 1:1 mix of susceptible and resistant bacteria was applied on the forearms of 12 volunteers. Competition was monitored by sampling bacteria from skin and determining their relative numbers.
Results: Resistance to ciprofloxacin due to parC mutations did not decrease the growth rate in vitro, and the CipR/CipS ratio was close to 1 during day 1 and 3 in the in vivo competition experiments. In contrast, fusidic acid resistance due to fusA mutations resulted in a decrease in the growth rate in vitro and a considerable loss of fitness in the competition. The FusR/FusS ratio diminished from 1.3 to 0.023 in 3 days.
Conclusions: These data show that human volunteers can be used as a simple and relevant model to study the biological cost of resistance.
Keywords: antibiotic resistance, biological fitness cost, human in vivo model
* Corresponding author. Tel: +46-18-611-39-11; Fax: +46-18-55-73-01; E-mail: ingegerd.gustafsson{at}medsci.uu.se
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. L. Rogers, M. E. Rupp, and P. D. Fey The Presence of icaADBC Is Detrimental to the Colonization of Human Skin by Staphylococcus epidermidis Appl. Envir. Microbiol., October 1, 2008; 74(19): 6155 - 6157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Rozen, L. McGee, B. R. Levin, and K. P. Klugman Fitness Costs of Fluoroquinolone Resistance in Streptococcus pneumoniae Antimicrob. Agents Chemother., February 1, 2007; 51(2): 412 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Roux, S. Giancola, S. Durand, and X. Reboud Building of an Experimental Cline With Arabidopsis thaliana to Estimate Herbicide Fitness Cost Genetics, June 1, 2006; 173(2): 1023 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Huovinen Mathematical model--tell us the future! J. Antimicrob. Chemother., August 1, 2005; 56(2): 257 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zhong, A. Pai, and G. Yan Costly Resistance to Parasitism: Evidence From Simultaneous Quantitative Trait Loci Mapping for Resistance and Fitness in Tribolium castaneum Genetics, April 1, 2005; 169(4): 2127 - 2135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Luo, S. Pereira, O. Sahin, J. Lin, S. Huang, L. Michel, and Q. Zhang Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure PNAS, January 18, 2005; 102(3): 541 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. V. Kern, M. Steib-Bauert, K. de With, S. Reuter, H. Bertz, U. Frank, and H. von Baum Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002 J. Antimicrob. Chemother., January 1, 2005; 55(1): 57 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. McBain, R. G. Ledder, L. E. Moore, C. E. Catrenich, and P. Gilbert Effects of Quaternary-Ammonium-Based Formulations on Bacterial Community Dynamics and Antimicrobial Susceptibility Appl. Envir. Microbiol., June 1, 2004; 70(6): 3449 - 3456. [Abstract] [Full Text] [PDF]
|
|